JP2007502844A5 - - Google Patents

Download PDF

Info

Publication number
JP2007502844A5
JP2007502844A5 JP2006524107A JP2006524107A JP2007502844A5 JP 2007502844 A5 JP2007502844 A5 JP 2007502844A5 JP 2006524107 A JP2006524107 A JP 2006524107A JP 2006524107 A JP2006524107 A JP 2006524107A JP 2007502844 A5 JP2007502844 A5 JP 2007502844A5
Authority
JP
Japan
Prior art keywords
mmol
reaction
give
ethyl acetate
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006524107A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007502844A (ja
Filing date
Publication date
Priority claimed from US10/922,362 external-priority patent/US7256207B2/en
Application filed filed Critical
Publication of JP2007502844A publication Critical patent/JP2007502844A/ja
Publication of JP2007502844A5 publication Critical patent/JP2007502844A5/ja
Pending legal-status Critical Current

Links

JP2006524107A 2003-08-20 2004-08-19 カテプシンsの阻害剤 Pending JP2007502844A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49685803P 2003-08-20 2003-08-20
US10/922,362 US7256207B2 (en) 2003-08-20 2004-08-18 Inhibitors of cathepsin S
PCT/US2004/027316 WO2005018568A2 (en) 2003-08-20 2004-08-19 Inhibitors of cathepsin s

Publications (2)

Publication Number Publication Date
JP2007502844A JP2007502844A (ja) 2007-02-15
JP2007502844A5 true JP2007502844A5 (https=) 2007-10-04

Family

ID=34221426

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006524107A Pending JP2007502844A (ja) 2003-08-20 2004-08-19 カテプシンsの阻害剤

Country Status (8)

Country Link
US (2) US7256207B2 (https=)
EP (1) EP1658274A4 (https=)
JP (1) JP2007502844A (https=)
AU (1) AU2004266151B2 (https=)
BR (1) BRPI0413755A (https=)
CA (1) CA2534489A1 (https=)
MX (1) MXPA06001888A (https=)
WO (1) WO2005018568A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7256207B2 (en) * 2003-08-20 2007-08-14 Irm Llc Inhibitors of cathepsin S
TWI389897B (zh) 2005-02-22 2013-03-21 Chugai Pharmaceutical Co Ltd 1- (2H) -isoquinolinone derivatives
US7751835B2 (en) * 2005-10-04 2010-07-06 Airvana, Inc. Non-circular paging areas
WO2011069298A1 (en) * 2009-12-11 2011-06-16 F. Hoffmann-La Roche Ag Novel cyclopropane indolinone derivatives
GB2476823B (en) 2010-01-11 2012-05-02 Subsea 7 Contracting Uk Ltd Improvements relating to abandonment and recovery of pipelines
CN113272286B (zh) * 2019-01-22 2024-04-16 阿德弗里奥药品有限责任公司 制备4-(2,2,3,3-四氟丙基)吗啉的方法
WO2020201572A1 (en) 2019-04-05 2020-10-08 Université De Bretagne Occidentale Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499295A (en) * 1983-05-09 1985-02-12 G. D. Searle & Co. Protease inhibitors
US5374623A (en) * 1992-08-20 1994-12-20 Prototek, Inc. Cysteine protease inhibitors effective for in vivo use
EP0648740B1 (en) * 1993-04-28 1997-10-08 Kumiai Chemical Industry Co., Ltd. Amino acid amide derivative, agrohorticultural bactericide, and production process
US5648514A (en) 1994-12-29 1997-07-15 Allergan Substituted acetylenes having retinoid-like biological activity
US5691368A (en) * 1995-01-11 1997-11-25 Hoechst Marion Roussel, Inc. Substituted oxazolidine calpain and/or cathepsin B inhibitors
US5849711A (en) * 1995-06-06 1998-12-15 Athena Neurosciences, Inc. Cathepsin and methods and compositions for inhibition thereof
TW438591B (en) * 1995-06-07 2001-06-07 Arris Pharm Corp Reversible cysteine protease inhibitors
SK48198A3 (en) * 1995-10-30 1998-10-07 Smithkline Beecham Corp Cathepsin k molecule, a peptid being bonded to the hollow of active positon of cathepsin k, a composition, method for identification of inhibiting compound and inhibitors being competitively bonded to the active position of cathepsin k
WO1997016433A1 (en) * 1995-10-30 1997-05-09 Smithkline Beecham Corporation Protease inhibitors
DE19610784A1 (de) * 1996-03-19 1997-09-25 Hoechst Ag Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung
US5840733A (en) 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5916887A (en) * 1996-09-23 1999-06-29 National Research Council Of Canada 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
US6004933A (en) * 1997-04-25 1999-12-21 Cortech Inc. Cysteine protease inhibitors
TR199902752T2 (xx) * 1997-05-08 2000-06-21 Smithkline Beecham Corporation Proteaz inhibit�rleri.
GB9723407D0 (en) * 1997-11-05 1998-01-07 Ciba Geigy Ag Organic compounds
GB9903548D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
EP1159273A1 (en) * 1999-03-02 2001-12-05 Boehringer Ingelheim Pharmaceuticals Inc. Compounds useful as reversible inhibitors of cathepsin s
DE60021254T2 (de) * 1999-03-15 2006-04-20 AXYS Pharmaceuticals, Inc., South San Francisco N-cyanomethylamide als protease inhibitoren
CA2379747C (en) * 1999-07-30 2008-09-23 Boehringer Ingelheim Pharmaceuticals, Inc. Novel succinate derivative compounds useful as cysteine protease inhibitors
US6420364B1 (en) * 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
ES2199856T3 (es) 1999-09-13 2004-03-01 Boehringer Ingelheim Pharmaceuticals, Inc. Nuevos compuestos heterociclicos, utiles como inhibidores reversibles de cisteina proteasas.
KR100523119B1 (ko) * 2000-03-16 2005-10-20 에프. 호프만-라 로슈 아게 Ip 길항제로서의 카복실산 유도체
EP1309591B1 (en) 2000-08-14 2007-01-24 Ortho-McNeil Pharmaceutical, Inc. Substituted pyrazoles
EP1309593B1 (en) 2000-08-14 2006-03-15 Ortho-McNeil Pharmaceutical, Inc. Substituted pyrazoles
HK1052705B (en) 2000-08-14 2006-09-29 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazole
MXPA03005601A (es) 2000-12-22 2004-12-02 Axys Pharm Inc Nuevos compuestos y composiciones como inhibidores de catepsina.
AU2002242500A1 (en) 2001-03-02 2002-09-19 Merck Frosst Canada And Co. Cathepsin cysteine protease inhibitors
CA2439415C (en) 2001-03-02 2011-09-20 Merck Frosst Canada & Co. Cathepsin cysteine protease inhibitors
WO2002070519A1 (en) 2001-03-05 2002-09-12 Axys Pharmaceuticals, Inc. Monobactams as cathepsin k inhibitors
EP1411933A1 (en) 2001-08-03 2004-04-28 SmithKline Beecham Corporation Alpha-ketoamide derivatives as cathepsin k inhibitors
US20030144234A1 (en) 2001-08-30 2003-07-31 Buxton Francis Paul Methods for the treatment of chronic pain and compositions therefor
EP1448554A1 (en) * 2001-10-09 2004-08-25 SmithKline Beecham Corporation Propylcarbamate derivatives as inhibitors of serine and cysteine proteases
US7101880B2 (en) * 2002-06-24 2006-09-05 Schering Aktiengesellschaft Peptidic compounds as cysteine protease inhibitors
US7256207B2 (en) * 2003-08-20 2007-08-14 Irm Llc Inhibitors of cathepsin S

Similar Documents

Publication Publication Date Title
Stymiest et al. Lithiated carbamates: chiral carbenoids for iterative homologation of boranes and boronic esters
JP3248760B2 (ja) ピラノン類およびピランジオン類の製造方法
JP2009525279A5 (https=)
JP2004527511A5 (https=)
JP5371033B2 (ja) 3官能ニトリルオキシドおよびその製造方法
JP2007502844A5 (https=)
CA3005744A1 (en) 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-oxoethyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
JP2006519814A5 (https=)
JP2006514107A5 (https=)
Batey et al. A new protocol for the formation of carbamates and thiocarbamates using carbamoyl imidazolium salts
Lu et al. A simple and convenient synthesis of 2-(perfluoroalkyl)-4H-chromenes from salicyl N-tosylimines or salicylaldehydes and methyl 2-perfluoroalkynoates
JP2001220387A (ja) 3,6−ジアルキル−5,6−ジヒドロ−4−ヒドロキシ−2h−ピラン−2−イルの合成
JPWO2004005276A1 (ja) 1,3−ベンゾジオキソール−2−スピロシクロアルカン誘導体の製造法
WO2015051762A1 (zh) 马沙骨化醇的合成中间体及其制备方法和用途
JPS6247190B2 (https=)
Kaburagi et al. 4-(tert-Butyldimethylsilyloxy) benzylidene acetal: a novel benzylidene-type protecting group for 1, 2-diols
JP2007506698A5 (https=)
JP4016414B2 (ja) 新規デンドリマー及びその製造方法
US20130109720A1 (en) Indole inhibitors of crac
JP4367627B2 (ja) エチニル置換された環状フルオロオレフィン化合物及びその製造方法
CN114466881A (zh) 含氟代聚醚基化合物
Milcent et al. Trifluoromethyl nitrones: from fluoral to optically active hydroxylamines
Jung et al. Efficient method for β-conjugate addition of α, β-unsaturated lactones and esters
CN113754616B (zh) 一种反式-3-苯硫基-γ-内酯的制备方法
JPH0220626B2 (https=)